These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9593009)

  • 21. The antibody response to SIV in lactating rhesus macaques.
    Rychert J; Amedee AM
    J Acquir Immune Defic Syndr; 2005 Feb; 38(2):135-41. PubMed ID: 15671797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting.
    Patterson LJ; Malkevitch N; Venzon D; Pinczewski J; Gómez-Román VR; Wang L; Kalyanaraman VS; Markham PD; Robey FA; Robert-Guroff M
    J Virol; 2004 Mar; 78(5):2212-21. PubMed ID: 14963117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA.
    Van Rompay KK; Miller MD; Marthas ML; Margot NA; Dailey PJ; Canfield DR; Tarara RP; Cherrington JM; Aguirre NL; Bischofberger N; Pedersen NC
    J Virol; 2000 Feb; 74(4):1767-74. PubMed ID: 10644348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239.
    Evans DT; Bricker JE; Sanford HB; Lang S; Carville A; Richardson BA; Piatak M; Lifson JD; Mansfield KG; Desrosiers RC
    J Virol; 2005 Jun; 79(12):7707-20. PubMed ID: 15919923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal or neonatal infection with attenuated simian immunodeficiency virus results in protective immunity against oral challenge with pathogenic SIVmac251.
    Otsyula MG; Miller CJ; Tarantal AF; Marthas ML; Greene TP; Collins JR; van Rompay KK; McChesney MB
    Virology; 1996 Aug; 222(1):275-8. PubMed ID: 8806509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies.
    Ferrantelli F; Rasmussen RA; Buckley KA; Li PL; Wang T; Montefiori DC; Katinger H; Stiegler G; Anderson DC; McClure HM; Ruprecht RM
    J Infect Dis; 2004 Jun; 189(12):2167-73. PubMed ID: 15181562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen.
    Lehner T; Tao L; Panagiotidi C; Klavinskis LS; Brookes R; Hussain L; Meyers N; Adams SE; Gearing AJ; Bergmeier LA
    J Virol; 1994 Mar; 68(3):1624-32. PubMed ID: 8107223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis.
    Sequar G; Britt WJ; Lakeman FD; Lockridge KM; Tarara RP; Canfield DR; Zhou SS; Gardner MB; Barry PA
    J Virol; 2002 Aug; 76(15):7661-71. PubMed ID: 12097580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral transmission of primate lentiviruses.
    Ruprecht RM; Baba TW; Liska V; Ray NB; Martin LN; Murphey-Corb M; Rizvi TA; Bernacky BJ; Keeling ME; McClure HM; Andersen J
    J Infect Dis; 1999 May; 179 Suppl 3():S408-12. PubMed ID: 10099108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus.
    Smith MO; Heyes MP; Lackner AA
    Lab Invest; 1995 May; 72(5):547-58. PubMed ID: 7745949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques.
    Schäfer F; Kewenig S; Stolte N; Stahl-Hennig C; Stallmach A; Kaup FJ; Zeitz M; Schneider T
    Gut; 2002 May; 50(5):608-14. PubMed ID: 11950804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal innate immune response associated with a timely humoral immune response and slower disease progression after oral transmission of simian immunodeficiency virus to rhesus macaques.
    Milush JM; Stefano-Cole K; Schmidt K; Durudas A; Pandrea I; Sodora DL
    J Virol; 2007 Jun; 81(12):6175-86. PubMed ID: 17428863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrathecal synthesis of IgG in simian immunodeficiency virus (SIV)-infected rhesus macaques (Macaca mulatta).
    Smith MO; Sutjipto S; Lackner AA
    AIDS Res Hum Retroviruses; 1994 Jan; 10(1):81-9. PubMed ID: 8179966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral SIV, SHIV, and HIV type 1 infection.
    Ruprecht RM; Baba TW; Liska V; Ayehunie S; Andersen J; Montefiori DC; Trichel A; Murphey-Corb M; Martin L; Rizvi TA; Bernacky BJ; Buchl SJ; Keeling M
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S97-103. PubMed ID: 9581893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Similar abnormalities of idiotype and immunoglobulin light chain expression and of cell-mediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV)-infected rhesus macaques.
    Grant MD; Whaley MD; Mayne A; Hoffmann GW; Ansari AA
    Immunol Cell Biol; 1996 Feb; 74(1):38-44. PubMed ID: 8934652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations.
    Ma ZM; Abel K; Rourke T; Wang Y; Miller CJ
    J Virol; 2004 Dec; 78(24):14048-52. PubMed ID: 15564513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of simian immunodeficiency virus and human immunodeficiency virus type 2 capsid antigens by a monoclonal antibody-based antigen capture assay.
    Lairmore MD; Hofheinz DE; Letvin NL; Stoner CS; Pearlman S; Toedter GP
    AIDS Res Hum Retroviruses; 1993 Jun; 9(6):565-71. PubMed ID: 7688521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of Plasma Cell Niche Factors on the Recruitment and Maintenance of IRF4hi Plasma Cells and Plasmablasts in Vaccinated, Simian Immunodeficiency Virus-Infected Rhesus Macaques with Low and High Viremia.
    Shaw JM; Miller-Novak LK; Mohanram V; McKinnon K; Demberg T; Vargas-Inchaustegui DA; Venzon D; Robert-Guroff M
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques.
    Greenier JL; Miller CJ; Lu D; Dailey PJ; Lü FX; Kunstman KJ; Wolinsky SM; Marthas ML
    J Virol; 2001 Apr; 75(8):3753-65. PubMed ID: 11264364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.